Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study

ABSTRACT Background and Aims This retrospective cohort study aimed to determine the utilization rate of statin therapy for primary prevention of cardiovascular disease (CVD) and factors associated with its use in patients prior to experiencing their first ST‐elevation myocardial infarction (STEMI)....

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah Faiz Zaihan, Shairyzah Ahmad Hisham, Aina Yazrin Ali Nasiruddin, Chia Siang Kow, Syed Shahzad Hasan, Dinesh Sangarran Ramachandram
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Health Science Reports
Subjects:
Online Access:https://doi.org/10.1002/hsr2.70206
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850207480172249088
author Abdullah Faiz Zaihan
Shairyzah Ahmad Hisham
Aina Yazrin Ali Nasiruddin
Chia Siang Kow
Syed Shahzad Hasan
Dinesh Sangarran Ramachandram
author_facet Abdullah Faiz Zaihan
Shairyzah Ahmad Hisham
Aina Yazrin Ali Nasiruddin
Chia Siang Kow
Syed Shahzad Hasan
Dinesh Sangarran Ramachandram
author_sort Abdullah Faiz Zaihan
collection DOAJ
description ABSTRACT Background and Aims This retrospective cohort study aimed to determine the utilization rate of statin therapy for primary prevention of cardiovascular disease (CVD) and factors associated with its use in patients prior to experiencing their first ST‐elevation myocardial infarction (STEMI). Methods The study included 177 patients admitted for their first episode of STEMI at a Malaysian secondary hospital in 2020. Data were retrospectively collected from the electronic health information system. Logistic regression analysis was performed to identify significant predictors of statin therapy utilization for primary prevention. Results Of the 177 patients, only 15.8% (n = 28) had been prescribed statin therapy for the primary prevention of CVD prior to their first STEMI. Hypertension and dyslipidemia were identified as significant predictors of statin use, with adjusted odds ratios (AOR) of 9.570 (95% CI: 1.859–49.281) and 37.900 (95% CI: 6.716–213.87), respectively. Follow‐up data indicated significantly reduced cholesterol levels post‐STEMI, demonstrating the lipid‐lowering effectiveness of statin therapy. Conclusion This study highlights the low utilization rate of statin therapy for primary prevention of CVD among patients prior to their first STEMI. Despite the proven effectiveness of statins in lowering cholesterol levels post‐STEMI, there is a need to enhance awareness, adherence to guidelines, and efforts to achieve LDL‐C targets through appropriate statin therapy.
format Article
id doaj-art-f3ed93ccb251447780b95740159cd9cf
institution OA Journals
issn 2398-8835
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series Health Science Reports
spelling doaj-art-f3ed93ccb251447780b95740159cd9cf2025-08-20T02:10:31ZengWileyHealth Science Reports2398-88352025-03-0183n/an/a10.1002/hsr2.70206Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort StudyAbdullah Faiz Zaihan0Shairyzah Ahmad Hisham1Aina Yazrin Ali Nasiruddin2Chia Siang Kow3Syed Shahzad Hasan4Dinesh Sangarran Ramachandram5Department of Pharmacy Shah Alam Hospital Shah Alam Selangor MalaysiaSchool of Pharmacy University of Nottingham Malaysia Semenyih Selangor MalaysiaSchool of Pharmacy University of Nottingham Malaysia Semenyih Selangor MalaysiaSchool of Pharmacy IMU University Kuala Lumpur Federal Territory of Kuala Lumpur MalaysiaSchool of Applied Sciences University of Huddersfield Queensgate Huddersfield UKSchool of Pharmacy Monash University Malaysia Subang Jaya Selangor MalaysiaABSTRACT Background and Aims This retrospective cohort study aimed to determine the utilization rate of statin therapy for primary prevention of cardiovascular disease (CVD) and factors associated with its use in patients prior to experiencing their first ST‐elevation myocardial infarction (STEMI). Methods The study included 177 patients admitted for their first episode of STEMI at a Malaysian secondary hospital in 2020. Data were retrospectively collected from the electronic health information system. Logistic regression analysis was performed to identify significant predictors of statin therapy utilization for primary prevention. Results Of the 177 patients, only 15.8% (n = 28) had been prescribed statin therapy for the primary prevention of CVD prior to their first STEMI. Hypertension and dyslipidemia were identified as significant predictors of statin use, with adjusted odds ratios (AOR) of 9.570 (95% CI: 1.859–49.281) and 37.900 (95% CI: 6.716–213.87), respectively. Follow‐up data indicated significantly reduced cholesterol levels post‐STEMI, demonstrating the lipid‐lowering effectiveness of statin therapy. Conclusion This study highlights the low utilization rate of statin therapy for primary prevention of CVD among patients prior to their first STEMI. Despite the proven effectiveness of statins in lowering cholesterol levels post‐STEMI, there is a need to enhance awareness, adherence to guidelines, and efforts to achieve LDL‐C targets through appropriate statin therapy.https://doi.org/10.1002/hsr2.70206acute coronary syndromediabetesHMG‐CoA reductase inhibitorlipid loweringprophylaxis
spellingShingle Abdullah Faiz Zaihan
Shairyzah Ahmad Hisham
Aina Yazrin Ali Nasiruddin
Chia Siang Kow
Syed Shahzad Hasan
Dinesh Sangarran Ramachandram
Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
Health Science Reports
acute coronary syndrome
diabetes
HMG‐CoA reductase inhibitor
lipid lowering
prophylaxis
title Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
title_full Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
title_fullStr Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
title_full_unstemmed Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
title_short Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
title_sort statin utilization for primary prevention of cardiovascular disease in patients developing first st segment elevation myocardial infarction a malaysian retrospective cohort study
topic acute coronary syndrome
diabetes
HMG‐CoA reductase inhibitor
lipid lowering
prophylaxis
url https://doi.org/10.1002/hsr2.70206
work_keys_str_mv AT abdullahfaizzaihan statinutilizationforprimarypreventionofcardiovasculardiseaseinpatientsdevelopingfirststsegmentelevationmyocardialinfarctionamalaysianretrospectivecohortstudy
AT shairyzahahmadhisham statinutilizationforprimarypreventionofcardiovasculardiseaseinpatientsdevelopingfirststsegmentelevationmyocardialinfarctionamalaysianretrospectivecohortstudy
AT ainayazrinalinasiruddin statinutilizationforprimarypreventionofcardiovasculardiseaseinpatientsdevelopingfirststsegmentelevationmyocardialinfarctionamalaysianretrospectivecohortstudy
AT chiasiangkow statinutilizationforprimarypreventionofcardiovasculardiseaseinpatientsdevelopingfirststsegmentelevationmyocardialinfarctionamalaysianretrospectivecohortstudy
AT syedshahzadhasan statinutilizationforprimarypreventionofcardiovasculardiseaseinpatientsdevelopingfirststsegmentelevationmyocardialinfarctionamalaysianretrospectivecohortstudy
AT dineshsangarranramachandram statinutilizationforprimarypreventionofcardiovasculardiseaseinpatientsdevelopingfirststsegmentelevationmyocardialinfarctionamalaysianretrospectivecohortstudy